Geneos Wealth Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Geneos Wealth Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-106	Closed	-$4K	–	2620
2022 Q2	$4K	Hold	106	–	–	﹤0.01%	2288
2022 Q1	$4K	Hold	106	–	–	﹤0.01%	2436
2021 Q4	$4K	Hold	106	–	–	﹤0.01%	2495
2021 Q3	$5K	Sell	106 -150	-59%	-$7.45K	﹤0.01%	2479
2021 Q2	$13K	Hold	256	–	–	﹤0.01%	2109
2021 Q1	$12K	Hold	256	–	–	﹤0.01%	2313
2020 Q4	$12K	Hold	256	–	–	﹤0.01%	2161
2020 Q3	$10K	Hold	256	–	–	﹤0.01%	1958
2020 Q2	$10K	Buy	256 +150	+142%	+$6.2K	﹤0.01%	1930
2020 Q1	$3K	Hold	106	–	–	﹤0.01%	2217
2019 Q4	$4K	Hold	106	–	–	﹤0.01%	2268
2019 Q3	$3K	Hold	106	–	–	﹤0.01%	2262
2019 Q2	$4K	Hold	106	–	–	﹤0.01%	2183
2019 Q1	$4K	Hold	106	–	–	﹤0.01%	2117
2018 Q4	$3K	Hold	106	–	–	﹤0.01%	2148
2018 Q3	$5K	Hold	106	–	–	﹤0.01%	2076
2018 Q2	$4K	Hold	106	–	–	﹤0.01%	2003
2018 Q1	$4K	Hold	106	–	–	﹤0.01%	1920
2017 Q4	$4K	Sell	106 -63	-37%	-$2.68K	﹤0.01%	1899
2017 Q3	$7K	Buy	169 +63	+59%	+$2.67K	﹤0.01%	1697
2017 Q2	$4K	Hold	106	–	–	﹤0.01%	1816
2017 Q1	$4K	Sell	106 -50	-32%	-$2.04K	﹤0.01%	1764
2016 Q4	$6K	Hold	156	–	–	﹤0.01%	1604
2016 Q3	$6K	Hold	156	–	–	﹤0.01%	1535
2016 Q2	$6K	Buy	156 +50	+47%	+$2.12K	﹤0.01%	1489
2016 Q1	$4K	Buy	+106	New	+$4.49K	﹤0.01%	1572

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Geneos Wealth Management's XPH Position: Q3 2022 in Review

Geneos Wealth Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2022, closing a stake of 106 shares — an estimated $4K sold.

Geneos Wealth Management first reported a position in XPH in Q1 2016 and held it in 26 quarters. The position peaked at $13K in Q2 2021. 66 funds tracked by Wall St. Rank hold XPH as of Q3 2022.

Geneos Wealth Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 106 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2022, an estimated $4K.
Geneos Wealth Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2016 and held it in 26 quarters.
Geneos Wealth Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $13K in Q2 2021.
66 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.